AIT Therapeutics Inc Share Price Nasdaq
Equities
US0014481099
Medical Equipment, Supplies & Distribution
Sales 2024 * | 14.38L 12Cr | Sales 2025 * | 1.32Cr 109.9Cr | Capitalization | 6.29Cr 523.7Cr |
---|---|---|---|---|---|
Net income 2024 * | -6.2Cr -516.36Cr | Net income 2025 * | -6.4Cr -533.02Cr | EV / Sales 2024 * | 35.3 x |
Net cash position 2024 * | 1.21Cr 101.18Cr | Net Debt 2025 * | 29.5L 25Cr | EV / Sales 2025 * | 4.99 x |
P/E ratio 2024 * |
-0.71
x | P/E ratio 2025 * |
-0.78
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 82.02% |
Latest transcript on AIT Therapeutics Inc
Managers | Title | Age | Since |
---|---|---|---|
Steven Lisi
CEO | Chief Executive Officer | 53 | 13/17/13 |
Douglas Larson
DFI | Director of Finance/CFO | 53 | 01/21/01 |
Amir Avniel
PSD | President | 50 | 13/17/13 |
Members of the board | Title | Age | Since |
---|---|---|---|
Ronald Bentsur
BRD | Director/Board Member | 58 | 01/15/01 |
William Forbes
BRD | Director/Board Member | 62 | 13/18/13 |
Erick Lucera
BRD | Director/Board Member | 57 | 10/17/10 |
1st Jan change | Capi. | |
---|---|---|
-5.43% | 18TCr | |
+4.30% | 11TCr | |
-3.09% | 6.83TCr | |
+5.86% | 5.22TCr | |
+8.15% | 4.43TCr | |
+7.69% | 4.27TCr | |
+25.54% | 3.25TCr | |
+21.25% | 2.6TCr | |
+1.00% | 2.59TCr |